Introduction
The leukocyte common antigens, defined by CD45, are a family of transmembrane protein tyrosine phosphatases (PTPase) expressed by T cells as well as by many other hematopoietic cells (1-3, reviewed in 4) . Cellular studies have shown that most mAb against CD45 inhibit T cell blastogenesis and/or inhibit TCR-mediated biochemical responses alone or have no effect (reviewed in 5) A limited number of anti-CD45 mAb have been shown to augment, rather than inhibit, T cell blastogenesis (6) (7) (8) (9) (10) (11) . The physiological ligand for CD45 has yet to be firmly established. Recent evidence suggests that the 8 cell surface molecule CD22, which binds sialic acid residues on AAlinked oligosaccharides, and /or galectin 1 may be a ligand for CD45 (12) (13) (14) .
Studies using T cell clones, deficient in CD45 expression, have demonstrated that CD45 is a necessary element in TCRmediated signal transduction (6, (15) (16) (17) (18) (19) (20) . Antigen-specific T cell lines that have lost expression of CD45 fail to proliferate in response to antigen and have defects in tyrosine phosphorylation of TCR signaling proteins. Mice, in which the expression of CD45 is blocked, have a variety of lymphocyte abnormalities, including incapacity of CD4/CD8 doublepositive cells to differentiate into CD8 or CD4 single-positive cells and poor T cell proliferative responses to TCR crosslinking (19) (20) (21) . Together these studies have shown that CD45 and its associated PTPase activity are key elements in the chain of events that originate at the level of the TCR and culminate in T lymphocyte proliferation.
In a previous report, we described a mAb (mAb NDA5) which recognizes a broadly distributed epitope of CD45. mAb NDA5 induces heterotypic and homotypic adhesion of lymphoid cells and enhances blastogenic responses of peripheral blood mononuclear cells (PBMC) to mitogens and soluble protein antigens (11) . Because of its co-stimulatory effect, this mAb provides a useful tool to investigate the possible physiological role of CD45 during T cell blastogenesis. In this report, we show that engagement of CD45 during antigenic stimulation enhances signaling events associated with T cell activation and results in an increase in the frequency of antigen-specific responding T cells.
Methods

Reagents
The anti-CD45 mAb NDA5 (IgM) was developed as previously described (11) . The hybridoma producing the anti-human CD3e-specific mAb, OKT3, was obtained from ATCC (Rockville, MD). mAb were purified from culture supernatants using Protein A affinity or size-exclusion gel filtration chromatography. Ig preparations were >95% pure as judged by reducing SDS-PAGE and silver staining. The purified control murine IgM (mAb MOPC 104E) and rabbit anti-mouse IgG were obtained from Sigma (St Louis, MO). The purified mAb UCHL1, recognizing the CD45 RO Pan T determinant, was obtained from Immunotech (Westbrook, MA) The purified biotinylated anti-phosphotyrosine IgG (mAb PY20) and Western blotting reagents were obtained from UBI (Lake Saranac, NY). Human recombinant IL-2 (rlL-2) was obtained from Boeringher Mannheim (Indianapolis, IN). Bovine serum albumin, phenylphosphate and sodium orthovanadate were obtained from Sigma. All other reagents were of the highest commercially available quality.
Peptide antigens
The synthetic peptide antigens used in these studies corresponded to a DR 11-restricted epitope of tetanus toxin, residues 830-843 (TT 830-843) (22) , and to the immunodominant core epitope of the DR1 p chain ailoantigen, residues 22-35 (DR1 p22-35) (23, 24) . Peptides were synthesized with an automated peptide synthesizer (430A; Applied Biosystems, Foster City, CA), using modified Merrifield chemistry. Following cleavage and deprotection, peptides were purified by preparative reverse-phase HPLC. The purity of the synthetic peptides, as determined by analytical reverse-phase HPLC and matrix assisted laser desorption ionization-time of flight mass spectrometry, was >95%.
Limiting dilution analysis of T h cell precursor reactivity to an immunodominant allopeptide antigen
PBMC were obtained from a healthy male volunteer carrying the DRB1*1101 allele. Cells were suspended at 1 x 10 6 cells/ ml in RPMI 1640 medium supplemented with 10% human AB serum, glutamine and gentamycin. PBMC were plated in 96-well trays at 5X10 4 3 H]thymidine incorporation greater than three times the background obtained from wells containing responding T cells and antigen-presenting cells but no peptide, and an absolute count of over 1000 c.p.m Estimation of the frequency of antigen-specific T cells was performed as previously described (25) .
T cell clones
The allopeptide-specific T cell clone (TCC)-LZ has been previously described (23, 24) . Blastogenesis studies were performed using responding T cells (2x10 4 
Phosphotyrosine immunoblotting
Purified T cells were obtained by sheep red blood cell rosetting from adherent-cell depleted PBMC. The purity of T cells was >92% CD3 + as determined immunofluorescent flow cytometry. T cells were suspended in prewarmed RPMI 1640 containing 10 mM HEPES, pH 7.4 at 2X10 6 cells/ml and 200 Hi aliquots were stimulated with the indicated antibodies for 10 or 20 min at 37°C. The reactions were terminated by pelleting the cells in a refrigerated microcentrifuge and replacing the supernatant with 200 |il reducing SDS-PAGE sample buffer supplemented with 10 mM sodium orthovanadate (27) . The samples were vortexed and incubated for 3 min at 100°C. Samples of the whole cell lysates (equivalent to 2X10 5 cells) were separated by reducing SDS-PAGE and then electrophoretically transferred to Immobilon (Millipore) membranes. Membranes were probed with biotinylated anti-phosphotyrosine mAb PY20 according to the manufacturers' recommendations. The addition of 10 mM phenylphosphate to the mAb PY20 solution used for immunoblotting abrogated all signals. • mAb NDA5 + DR 1 pep.
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-mAbNDAS Fig. 1 . Antigen-specific naive T cell frequencies are enhanced during in vitro priming with mAb NDA5. The frequency of reactive peptidespecific T cells was enumerated by limiting dilution assay. The wells showing proliferative responses of >1000 cpm and three times higher than the background were scored as positive. For in vitro priming, the concentration of mAb NDA5 or control IgM MOPC 104E was 5 jig/ml The peptide concentration used in loading the antigen-presenting cells for the limiting dilution assay was held constant at 5 ng/ml The results given are representative from two independent determinations for a male DR1101-positive responder
Immunofluorescent flow cytometry
Expression of CD3 and CD4 on PBMC was determined by immunofluorescent flow cytometry using a Becton Dickinson FACScan instrument and Cell Quest acquisition and analysis software. Isotype controls and specific FITC or phycoerythrinconjugated mAb recognizing CD3 and CD4 were obtained from Becton Dickinson (Mountain View, CA). Gates for forward and side scatter measurements were set on lymphocytes and a minimum of 50,000 events was acquired.
Results
Engagement of CD45 during antigen stimulation increases the frequency and reactivity of antigen-specific T cells
In previous studies we showed that ligation of CD45 by mAb NDA5 enhances T cell blastogenic responses to mitogens and soluble protein antigens. To determine whether the enhancement of blastogenesis was due to an increase in the frequency of responding T cells, the effects of mAb NDA5 on T cell reactivity to peptide antigens was analyzed using the technique of limiting dilution. The effect of mAb NDA5 on naive Tf, cells was measured using T lymphocytes from a healthy male volunteer (with no history of allosensitization) as responding cells and the DR1 22-35 peptide antigen (the immunodominant determinant of the HLA-DR 1 alloantigen) for stimulation (23) . The apparent precursor frequency of allopeptide reactive T h cells was significantly higher in the presence of mAb NDA5, indicating that engagement of the CD45 molecule during cross-linking of the TCR by MHC-peptide antigen complexes has a costimulatory effect (Fig. 1) .
The effect of mAb NDA5 on memory T h cells was determined using T cells from DR1101-positive individuals who had been previously immunized with tetanus toxoid. These T lymphocytes were stimulated with TT 830-843 representing an immunodominant determinant of tetanus toxin. The frequency of T h cells reacting to TT 830-843 was significantly higher (>5-fold) when T h cells were stimulated in the presence of mAb NDA5 (Fig. 2) . No blastogenic responses were detected in cultures without antigen. Similar to naive T h cells, long-lived memory T h cells are also susceptible to the costimulatory effect of CD45 ligation by mAb NDA5. Preliminary data show that conjugation of peptide antigens to the carbohydrate moieties of mAb NDA5 IgM yield an efficient vehicle for augmenting T h responses to peptide antigens (P. Harris, unpublished observations).
The effect of mAb NDA5 may reflect an increase in the total number of progeny of a T cell clone and/or the recruitment of additional T cell clones with different affinities for the ligand. Either mechanism is consistent with the possibility that ligation of CD45 during priming modifies the response of specific TCR to their ligands.
To establish whether the response of a single T cell clone to the peptide ligand is modified by CD45 ligation, mAb NDA5 was added to a T cell clone (TCC-LZ) specific for the DR1 22-35 peptide antigen and the blastogenic response to antigen was measured. At the optimum peptide concentration (1 nM), the blastogenic response of TCC-LZ was 2-fold higher in the presence of mAb NDA5 compared with cultures containing the control mAb (Fig. 3) . These data indicate that ligation of CD45 augments antigen-driven proliferation of single T cell clones. 
mAb NDA5 enhances tyrosine phosphorylation of intracellular proteins
Because CD45 protein tyrosine phosphatases are involved in regulation of sre family tyrosine kinases, enhancement of T cell proliferation by mAb NDA5 could be associated with alterations in protein tyrosine phosphorylation. To test this hypothesis, the tyrosine phosphorylation of substrate proteins during T cell activation by anti-CD3 mAb (mAb OKT3) in the presence of mAb NDA5 was studied. Peripheral T cells were stimulated with mAb OKT3 and anti-mlgG for various periods of time in the presence and absence of different concentrations of mAb NDA5. Whole cell lysates were separated by SDS-PAGE and the content of tyrosine-phosphorylated proteins was determined by Western blot using the antiphosphotyrosine mAb PY20.
As shown in Fig. 4 , cross-linking of the TCR for 10 min by mAb 0KT3 and anti-mlgG resulted in a moderate enhancement of the phosphotyrosine content (Fig. 4, lane C) . When cross-linking was carried out in the presence of mAb NDA5, there was a significant increase in the phosphotyrosine content of the activated cells (Fig. 4, lane D) . Control cells, that were not treated with OKT3, or treated instead with anti-mlgG and MOPC 104E (a control non-immune IgM), showed no enhancement of phosphotyrosine content (Fig. 4, lanes A and  F respectively) . The enhancement of tyrosine phosphorylation by mAb NDA5 was not dependent on its IgM structure, since the F(ab')2 fragment of the molecule was also active (Fig. 4 , lane E). As an additional negative control, T cells were incubated with mAb OKT3 and the CD45 RO mAb UCHL1 followed by anti-mlgG or with LJCHL1 alone. T cells treated in this manner showed a slight reduction in phosphotyrosine content compared to TCR cross-linked T cells (Fig. 4 , lanes I and H) as previously described (5) . As a positive control T cells were stimulated with OKT3 and anti-mlgG in the presence of 10 nM sodium orthovanadate (Fig. 4, lane K) . These cells showed enhanced phosphotyrosine content as a result of the broad inhibition of phosphatase activity mediated by vanadate ions. When mAb NDA5 was added alone to T cells, either in its native IgM form or as an F(ab')2 fragment, there was a slight increase in phosphotyrosine content compared to the control cells (Fig. 4 , lanes G and J), suggesting that some Reproducible enhancement of the tyrosine phosphorylation response to TCR cross-linking occurred at concentrations ranging from 1 to 5 |ig/ml (data not shown).
The effects of mAb NDA5 on tyrosine phosphorylation of anti-CD3 activated T cells were visible at 10 min and further enhanced during the following 10 min (Fig. 5, lane C) . The effect of mAb OKT 3 (Fig. 5, lane B) when used alone or in conjunction with mAb UCHL1 (Fig. 5, lane D) , which was inhibitory, became more evident after 20 min. In these experiments, several bands, corresponding to molecular masses of 14-18, 21-24, 30-40 and 54-64 kDa, appeared de novo or became more intensely stained, following ligation of CD45 by mAb NDA5, in a pattern consistent with previously reported data (28, 29) . These data demonstrate that ligation of CD45 by mAb NDA5 results in enhancement of tyrosine phosphorylation of T cell substrate proteins.
Engagement of CD45 can modulate cell surface expression of CD3 and CD4
Although treatment of T cells with mAb NDA5 alone did not stimulate proliferation, immunoblotting with anti-phosphotyrosine antibody showed that mAb NDA5 alone induced a slight increase in protein phosphotyrosine content, suggesting that some signaling activity was initiated by mAb NDA5 ligation of CD45. Since there is significant intracellular crosstalk among receptor molecules, cultures of PBMC treated with mAb NDA5 alone were examined for alterations in expression of cell surface receptor proteins during a 5 day culture period. Analysis of CD3 and CD4 expression after 12 h of culture showed that mAb NDA5 down-regulated the T cell surface expression of CD3 and CD4 (Fig. 6) . The cell concentration and viability in cultures containing mAb NDA5 was similar to that seen in cultures containing the control IgM MOPC 104E. Down-regulation of expression of CD3 and CD4 by mAb NDA5 occurred as early as 6 h after initiation of the culture returned gradually to normal levels by the end of the 5 day culture period (data not shown). These observations suggest that engagement of CD45 by mAb NDA5 transduces signals that operate independently of the TCR.
Discussion
T cell activation, proliferation and lymphokine secretion are essential to both cell-mediated and humoral immunity. This process of T cell activation requires transduction of distinct signals through interaction with antigen-presenting cells. The first signal confers antigen specificity and involves the molecular interaction between TCR-CD3 complex with antigenic peptide associated with MHC molecules on the antigenpresenting cell membrane. A series of experiments, in which recombinant or chimeric CD45 molecules have been introduced into CD45-deficient cells, have shown that CD45 PTPase activity is necessary for normal T cell signaling (16, (30) (31) (32) (33) (34) (35) . Furthermore, biochemical data has demonstrated a physical association between CD45 and the src-related tyrosine kinases (PTK), CD4-associated pbQ 10 * and the TCRassociated p59^" (29, 30, (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) . Together these studies suggest that CD45 PTPase is constitutively active and functions to maintain a permissive state for T cell responses to TCR signaling. It has been proposed that the level of basal PTK activity will determine the efficiency and kinetics of signal transduction: the more src family PTK that are activated at a given time, the stronger and more rapid the lymphocyte response to antigen (49) .
While signals from the CD3-TCR complex, induced by antigenic peptide-MHC complexes, are necessary, they are not sufficient for T cell proliferation. The complete process depends on co-stimulatory signals that augment T cell proliferation and effector functions. Several molecules such as CD80, CD70 and possibly CD22, expressed by antigenpresenting cells, act as co-stimulatory ligands. CD22 may be a B cell ligand for CD45 expressed on T cells, since soluble CD22 fusion protein has been shown to bind CD45 and stimulate T cell protein tyrosine phosphorylation (12, 13) . The CD22-CD45 interaction may be important for T-B cell cooperation.
The expansion of a T cell clone is likely to be a tightly regulated process, depending not only on the rate of growth, but on programmed cell death. Recently, it was demonstrated that the binding of human aortic endothelial cell galectin-1 to CD45 could induce T cell apoptosis. This effect was dependent on cross-linking of CD45 by galectin-1 and could be blocked by anti-CD45 antibodies (14) . Thus CD45, appears to be a nexus, where the balance between T cell activation, expansion and death can be modulated by external ligands.
Our present study is consistent with this hypothesis and demonstrates that engagement of CD45 on T lymphocytes can result in enhanced activation of antigen-specific progeny T helper cells following in vitro priming. This conclusion is drawn from experiments showing that protein tyrosine phosphorylation and T cell reactivity are augmented during in vitro priming in the presence of the anti-CD45 mAb NDA5. Although binding by mAb NDA5 to CD45 does not induce T cell proliferation in the absence of antigen, it seems to transduce signals which may be independent of the TCR. This view is supported by the observation that T cells display a rapid down-regulation of CD3 and CD4 expression when cultured with mAb NDA5. This process may be linked to CD45-mediated activation of sre-related PTK, since the internalization of CD3 and CD4 is regulated by certain kinases and phosphorylation of CD3 or CD4 at specific sites accompanies their internalization (50) (51) (52) .
